Flubromazepam is abenzodiazepine derivative which was first synthesized in 1960,[1] but was never marketed and did not receive any further attention or study until late 2012 when it appeared on thegrey market as a noveldesigner drug.[2][3][4][5][6][7][8]
An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one or "iso-flubromazepam",[9] may have been sold under the same name.[2]
In the UK, flubromazepam has been classified as aClass C drug by the May 2017 amendment toThe Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.[10]
^US 3136815, "Amino substituted benzophenone oximes and derivatives thereof"
^abMoosmann B, Huppertz LM, Hutter M, Buchwald A, Ferlaino S, Auwärter V (November 2013). "Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics".Journal of Mass Spectrometry.48 (11):1150–9.Bibcode:2013JMSp...48.1150M.doi:10.1002/jms.3279.PMID24259203.
^"Flubromazepam". New Synthetic Drugs Database. 12 November 2023. Archived fromthe original on 16 March 2022. Retrieved2 February 2016.
^Pettersson Bergstrand M, Helander A, Hansson T, Beck O (April 2017). "Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays".Drug Testing and Analysis.9 (4):640–645.doi:10.1002/dta.2003.PMID27366870.
^Høiseth G, Tuv SS, Karinen R (November 2016). "Blood concentrations of new designer benzodiazepines in forensic cases".Forensic Science International.268:35–38.doi:10.1016/j.forsciint.2016.09.006.PMID27685473.
